These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15261228

  • 21. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 22. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J, Jian Z, Huang L, Guo H, Huang J, Qian D, Fu W, Li A, Song Y.
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [Abstract] [Full Text] [Related]

  • 23. Single-dose pharmacodynamics of clopidogrel.
    Thebault JJ, Kieffer G, Cariou R.
    Semin Thromb Hemost; 1999 Sep; 25 Suppl 2():3-8. PubMed ID: 10440415
    [Abstract] [Full Text] [Related]

  • 24. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
    Tang YD, Rinder HM, Katz SD.
    Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296
    [Abstract] [Full Text] [Related]

  • 25. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.
    Thebault JJ, Kieffer G, Lowe GD, Nimmo WS, Cariou R.
    Semin Thromb Hemost; 1999 Sep; 25 Suppl 2():9-14. PubMed ID: 10440416
    [Abstract] [Full Text] [Related]

  • 26. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.
    Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G.
    Eur Heart J; 2006 May; 27(9):1038-47. PubMed ID: 16476694
    [Abstract] [Full Text] [Related]

  • 27. Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects.
    Payne CD, Li YG, Brandt JT, Jakubowski JA, Small DS, Farid NA, Salazar DE, Winters KJ.
    Platelets; 2008 Jun; 19(4):275-81. PubMed ID: 18569863
    [Abstract] [Full Text] [Related]

  • 28. A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel.
    Chen F, Maridakis V, O'neill EA, Beals C, Radziszewski W, de Lepeleire I, Van Dyck K, Depré M, Bolognese JA, de Hoon J, Jacquemin M.
    Platelets; 2012 Jun; 23(4):249-58. PubMed ID: 21919555
    [Abstract] [Full Text] [Related]

  • 29. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
    Lepäntalo A, Virtanen KS, Heikkilä J, Wartiovaara U, Lassila R.
    Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
    [Abstract] [Full Text] [Related]

  • 30. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH, Schmidt EB, Maurer-Spurej E, Kristensen SR.
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [Abstract] [Full Text] [Related]

  • 31. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers.
    Siller-Matula JM, Gouya G, Wolzt M, Jilma B.
    Thromb Haemost; 2009 Aug; 102(2):397-403. PubMed ID: 19652892
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
    Stellbaum C, Ayral Y, Morguet A, Schultheiss HP, Rauch U.
    Cardiovasc Revasc Med; 2012 Aug; 13(3):159-66. PubMed ID: 22503564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.